CMTX BIOTECH
CMTx Biotech is a clinical-stage biopharmaceutical company that focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients. It is currently preparing to advance into a Phase II clinical trial to demonstrate the safety and efficacy of its drug candidate in hospitalized COVID-19 patients. The company was founded in 2019 and is headquartered in Stony Brook, New York.
CMTX BIOTECH
Social Links:
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2019-01-01
Address:
Stony Brook, New York, United States
Country:
United States
Website Url:
http://www.cmtxbiotech.com
Total Employee:
1+
Status:
Active
Contact:
631 258 5680
Email Addresses:
[email protected]
Current Employees Featured
Founder
Official Site Inspections
http://www.cmtxbiotech.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "CMTx Biotech"
CMTx Biotech - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 631 258 5680 CMTx Biotech is a clinical-stage biopharmaceutical company that focuses on repurposing a clinical-stage small molecule …See details»
CMTX BIOTECH, INC. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for CMTX BIOTECH, INC. of Kings Park, NY. Get the latest business insights from Dun & Bradstreet.See details»
CMTx Biotech, Inc.: Contact Details and Business Profile
CMTx Biotech is commercializing a pipeline of proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations for the host-modulatory treatment of …See details»
CMTx Biotech, Inc. | LinkedIn
CMTx Biotech, Inc. Biotechnology Stony Brook, New York 1,400 followers Commercializing proprietary, non-antibiotic, chemically-modified tetracycline (CMT) compositions and formulations.See details»
CMTx Biotech 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for CMTx Biotech. Use the PitchBook Platform to explore the full profile.See details»
CMTx Biotech - Overview, News & Similar companies - ZoomInfo
View CMTx Biotech (www.cmtxbiotech.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as employees by title and …See details»
CMTx Biotech, Inc. Overview | SignalHire Company Profile
Organization Website: cmtxbiotech.com : Phone Number: 631-258-5680: CMTx Biotech, Inc. industries BiotechSee details»
Cmtx Biotech Company Profile -Sales, Contacts, Competitors – …
Cmtx Biotech is in the Biotechnical Research, Commercial industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for …See details»
CMTx Biotech
CMTx Biotech is focused on developing innovative therapies for rare and pandemic diseases. Their research centers around the repurposing of chemically-modified tetracycline (CMT) …See details»
CMTx Biotech - Products, Competitors, Financials, Employees ...
Cmtxbiotech.com. Overview & Products; Financials; People; Founded Year 2019. Stage Other Investors | Alive. About CMTx Biotech. CMTx Biotech focuses on developing small molecule …See details»
CMTx Biotech, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
There’s plenty of COVID-19-related news today. Here’s a look. Novavax Inks MoU with Gavi for 1.1 Billion Doses of COVID-19 Vaccine Novavax announced a Memorandum of Understanding …See details»
Cmtx Biotech Profile - highergov.com
Cmtx Biotech (UEI SQJJQU7ZLMB9, CAGE 89E03) based in Kings Park NY federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
CMTx Biotech | Company | RadialReport
CMTx Biotech focuses on repurposing a clinical-stage small molecule for the treatment of COVID-19 patients.See details»
Newsroom - CMTx Biotech, Inc.
Clinical Stage, SMALL MOLECULE Treatments for Rare & Pandemic DiseasesSee details»
Publications - CMTx Biotech, Inc.
Abstract Excerpt: Kaposi's sarcoma (KS) is an angioproliferative lesion that may regress or progress. Progression is related to spindle cell proliferation and the expression of human …See details»
CMTx Biotech, Inc. Receives $315,000 NCATS Grant
CMTx Biotech announced today that it has received a $315,000 Clinical Trial Planning Grant from the National Center for Advancing Translational Sciences (NCATS), one of the 27 Institutes …See details»
CMTx Biotech, Inc. Email Format | cmtxbiotech.com Emails
The most common CMTx Biotech, Inc. email format. is [first] (ex. [email protected]), which is being used by 100.0% of CMTx Biotech, Inc. work email addresses. CMTx Biotech, Inc. …See details»
Establishing Canada’s first large-scale bioinnovation centre
3 days ago The Neptune BioInnovation Centre (NBC), a 51,000 sq ft facility on a 12.3 acre lot in Dartmouth, will offer leasable wet and dry lab space, warehouse and office spaces, and …See details»
CMTx Biotech Executes Exclusive License Agreement with Galderma
Kings Park, NY; March 15, 2021: CMTx Biotech announced today that it has executed an exclusive, worldwide license agreement to develop and commercialize incyclinide, a clinical …See details»
CMTx Biotech Shifting to Meet Pandemic Needs
CMTx Biotech is in the news today as one of a few Long Island companies refocusing their efforts to help fight the COVID-19 pandemic. CMTx Biotech is repurposing a clinical stage drug …See details»